Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Consegna Pharma Logo
Consegna Pharma Growth Score
71
CB Rank
334734
Heat Score
61
Consegna reformulates FDA approved drugs and creates new, long-acting injectable (LAI) medications.
Founded
obfuscation
PrivateGrant Pittsburgh, Pennsylvania, United States11-50 www.consegnapharma.com/
Biotechnology
Pharmaceutical
Overview

Consegna Pharma
Growth Score
71
Heat Score
61

Growth Score71
-15 pts
in past quarter
Heat Score 61
-3 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Consegna Pharma

CB Rank
334734
Consegna reformulates FDA approved drugs and creates new, long-acting injectable (LAI) medications.
Founded
obfuscation
PrivateGrant Pittsburgh, Pennsylvania, United States11-50 www.consegnapharma.com/
Biotechnology
Pharmaceutical

Funding Rounds

Grant
OBF
in
obfuscation

Key People

  • Photo of Larry Zana
    Larry Zana: President , CEO , Founder & Director
    Past Role: Qrono, CEO

Details

Operating Status Active
Company Type For Profit
Founders  Larry Zana
About the Company

Consegna reformulates FDA approved drugs and creates new, long-acting injectable (LAI) medications with improved clinical and economic benefits. Our product pipeline focuses on therapeutic areas where LAIs offer high therapeutic and economic value, such as addressing high non-adherence, solving specific drug delivery challenges, or reducing side

effects.

Phone Number +1.412.213.8788
Contact Email info@consegnapharma.com
Predictions & Insights

Growth Insight

See this Growth Insight
Consegna Pharma is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction

Products & Services

CP216
A sustained-release naloxone formulation designed to prevent renarcotization by releasing naloxone over 24 hours, addressing opioid overdose challenges.
Computational Drug Delivery™ (ADSR™)
An AI-based software that calculates formulation specifications for long-acting injectables, reducing clinical trial and manufacturing risks.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Consegna Pharma Logo
Grant - Consegna Pharma
1
obfuscation
National Institute on Drug Abuse (NIDA)Grant
obfuscation
Grant - Consegna Pharma Logo
Grant - Consegna Pharma
1
obfuscation
National Institute on Drug Abuse (NIDA)Grant
obfuscation
Grant - Consegna Pharma Logo
Grant - Consegna Pharma
1
obfuscation
National Institute on Drug Abuse (NIDA)Grant
obfuscation
Grant - Consegna Pharma Logo
Grant - Consegna Pharma
1
obfuscation
National Institute on Drug Abuse (NIDA)Grant
obfuscation
Grant - Consegna Pharma Logo
Grant - Consegna Pharma
1
obfuscation
National Institute on Drug Abuse (NIDA)Grant

Funding Rounds

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Consegna Pharma Logo
Grant - Consegna Pharma
1
obfuscation
National Institute on Drug Abuse (NIDA)Grant
obfuscation
Grant - Consegna Pharma Logo
Grant - Consegna Pharma
1
obfuscation
National Institute on Drug Abuse (NIDA)Grant
obfuscation
Grant - Consegna Pharma Logo
Grant - Consegna Pharma
1
obfuscation
National Institute on Drug Abuse (NIDA)Grant
obfuscation
Grant - Consegna Pharma Logo
Grant - Consegna Pharma
1
obfuscation
National Institute on Drug Abuse (NIDA)Grant
obfuscation
Grant - Consegna Pharma Logo
Grant - Consegna Pharma
1
obfuscation
National Institute on Drug Abuse (NIDA)Grant

Investors

Investments

Number of Acquisitions 1

Investment Breakdown

Number of Acquisitions 1
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 1

Employee Profiles

News

News and Press

News•Feb 24, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Feb 24, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

758
982.86%
 in past month

IT Spend

$41KThis year, Consegna Pharma is projected to spend $41K on IT, according to Aberdeen.

Active Website Tech Count

3Consegna Pharma is actively using 3 technologies for its website, according to BuiltWith. These include Common Crawl, Euro, and  CommonCrawl Top 50m.

Total IP

2The intellectual property of Consegna Pharma includes 2 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations

Sub-Organizations

Number of Sub-Orgs 1
Which industries do these Sub-Organization operate in?
Fathom Pharma Logo
Fathom PharmaSubsidiary
Frequently Asked Questions

Where is Consegna Pharma's headquarters? Consegna Pharma is located in Pittsburgh, Pennsylvania, United States.Who invested in Consegna Pharma? Consegna Pharma is funded by National Institute on Drug Abuse (NIDA).When was the last funding round for Consegna Pharma? Consegna Pharma closed its last funding round on
obfuscation
from a Grant round.Who are Consegna Pharma's competitors? Alternatives and possible competitors to Consegna Pharma may include Theravance Biopharma, ViiV Healthcare, and  Intarcia Therapeutics.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8ea058e 1)
|